CN100335114C - Chinese medicinal liquor for treating alcoholic liver disease - Google Patents
Chinese medicinal liquor for treating alcoholic liver disease Download PDFInfo
- Publication number
- CN100335114C CN100335114C CNB2005100436717A CN200510043671A CN100335114C CN 100335114 C CN100335114 C CN 100335114C CN B2005100436717 A CNB2005100436717 A CN B2005100436717A CN 200510043671 A CN200510043671 A CN 200510043671A CN 100335114 C CN100335114 C CN 100335114C
- Authority
- CN
- China
- Prior art keywords
- present
- treating
- liver disease
- oral liquid
- alcoholic liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to traditional Chinese medicine oral liquor for treating alcoholic liver disease, which is characterized in that the present invention comprises the following raw materials of parts by weight: 0.5 to 20 of pueraria flower or pueraria root, 1 to 20 of schizandra sinensis or capillary artemisia, 1 to 20 of chicken's gizzard-membrane, 0.5 to 24 of alisma rhizome, 1 to 15 of raw barley sprout, 1 to 20 of dandelion, 0.1 to 10 of villous amomum fruit and 1 to 15 of dried tangerine peel, and also best comprises 0.5 to 10 of pharbitidis seed and 1 to 20 of atractylodes rhizome. By the clinical application, the effective rate of the present invention for treating alcoholic hepatitis can be up to more than 96%; simultaneously, the present invention has the better functions of relieving and treating dizziness, nausea and poor appetite caused by drunkenness, and also has the better effects on treating viral hepatitis and medicamentous liver lesion; the present invention has no toxic or side effect.
Description
Technical field
The invention belongs to Chinese medicine oral liquid, particularly a kind of Chinese medicine oral liquid of main treatment alcoholic liver disease.
Background technology
In recent years, alcoholic liver disease has the trend of showed increased, and especially alcoholic hepatitis has become the second largest hepatic disease that is only second to viral hepatitis in China.But still lack effective medicine at present.Though the report of treatment by Chinese herbs alcoholic liver disease is arranged, strict contrast and the objective observation index of lacking recently more.
Summary of the invention
Technical problem to be solved by this invention provides a kind of Chinese medicine oral liquid for the treatment of alcoholic liver disease, and the curative effect height has no side effect.
The present invention treats the Chinese medicine oral liquid of alcoholic liver disease, it is characterized in that it being that raw material by comprising following parts by weight is made: Flos puerariae lobatae 0.5～20, Radix Schisandrae Bicoloris 1～20, Endothelium Corneum Gigeriae Galli 1～20, Rhizoma Alismatis 0.5～24, Fructus Hordei Germinatus 1～15, Herba Taraxaci 1～20, Fructus Amomi 0.1～10, Pericarpium Citri Reticulatae 1～15.
Above-mentioned raw materials also preferably includes Semen Pharbitidis 0.5～10 and Rhizoma Atractylodis 1～20 in forming.
Wherein Flos puerariae lobatae can replace with Radix Puerariae, but preferred Flos puerariae lobatae; Radix Schisandrae Bicoloris can replace with Herba Artemisiae Scopariae, but preferred Radix Schisandrae Bicoloris.
Above-mentioned raw materials is that the common manufacture method according to oral liquid on the Chinese medicine and pharmacy is prepared into oral liquid.
In the above-mentioned prescription, Flos puerariae lobatae, Herba Taraxaci Dealcoholic sobering-up, clearing away heat and eliminating dampness; Pericarpium Citri Reticulatae, Fructus Amomi is drying damp and strengthening spleen; Rhizoma Alismatis, Fructus Hordei Germinatus diuresis eliminating dampness by diuresis, stomach function regulating helps digestion; Radix Schisandrae Bicoloris, Endothelium Corneum Gigeriae Galli the liver protecting and ALT lowering; Semen Pharbitidis is dispeled stagnant; Rhizoma Atractylodis are drying damp and strengthening spleen.Full side's compatibility is rigorous, reasonable, and the heat clearing away of gathering altogether relieves the effect of alcohol, drying damp and strengthening spleen effect.The existing good effect that improves symptom and recover liver function has no side effect taking convenience again.
Through clinical practice, treatment alcoholic hepatitis effective percentage can reach more than 96%; Simultaneously to the dizziness due to the drunk back, feel sick, inappetence has and alleviates preferably and therapeutical effect; Viral hepatitis and medicamentous liver lesion also there is better effects.Have no side effect.
Below sum up for clinical practice:
Use oral liquid treatment alcoholic hepatitis 56 examples of the present invention, obtained clinical efficacy preferably.
1, clinical data:
1.1 case is selected: this group case is outpatient service and ward patient, is the male, 28～68 years old age.
1.2 diagnostic criteria: the diagnostic criteria of formulating with hepatology branch of Chinese Medical Association (2002) Nanjing meeting is a foundation.
1.3 Therapeutic Method: 56 examples are organized in the treatment of this group case, matched group 48 examples, and matched group is given vitimin supplement C, vitamin B group, is taken the circumstances into consideration fluid infusion.The treatment group adds on the matched group basis uses oral liquid of the present invention 20ml/ time, and three times on the one, one month is a course of treatment.Two groups of all strict alleviatings alcohol addiction of patient.
2, observation of curative effect:
2.1 criterion of therapeutical effect:
Cure: cardinal symptom disappears, and liver function recovery is normal.
Effectively: cardinal symptom alleviates, and bilirubin, AST, GGT etc. descend 75%.
Invalid: symptom does not have improvement, and liver function does not have the improver.
2.2 two groups of curative effects relatively: the treatment group is cured 20 examples, effective 34 examples, invalid 2 examples, total effective rate 96.4%; Matched group is cured 12 examples, effective 26 examples, invalid 10 examples, total effective rate 79.2%.Learn by statistics and handle, there were significant differences (P＜0.05) for two groups of total effective rates.
The specific embodiment
Following examples are that the weight of raw material is formed, and prepare according to the preparation method of common oral liquid.
Embodiment 1: Flos puerariae lobatae 10, Radix Schisandrae Bicoloris 15, Endothelium Corneum Gigeriae Galli 13, Rhizoma Alismatis 18, Fructus Hordei Germinatus 5, Herba Taraxaci 16, Fructus Amomi 7, Pericarpium Citri Reticulatae 10.
Embodiment 2: Flos puerariae lobatae 5, Radix Schisandrae Bicoloris 8, Endothelium Corneum Gigeriae Galli 6, Rhizoma Alismatis 9, Fructus Hordei Germinatus 11, Herba Taraxaci 9, Fructus Amomi 4, Pericarpium Citri Reticulatae 12.
Embodiment 3: Flos puerariae lobatae 0.5, Radix Schisandrae Bicoloris 1, Endothelium Corneum Gigeriae Galli 3, Rhizoma Alismatis 5, Fructus Hordei Germinatus 1, Herba Taraxaci 6, Fructus Amomi 0.1, Pericarpium Citri Reticulatae 1, Semen Pharbitidis 0.5, Rhizoma Atractylodis 1.
Embodiment 4: Flos puerariae lobatae 2, Radix Schisandrae Bicoloris 6, Endothelium Corneum Gigeriae Galli 1, Rhizoma Alismatis 0.5, Fructus Hordei Germinatus 6, Herba Taraxaci 1, Fructus Amomi 2, Pericarpium Citri Reticulatae 3, Semen Pharbitidis 3, Rhizoma Atractylodis 3.
Embodiment 5: Radix Puerariae 20, Radix Schisandrae Bicoloris 18, Endothelium Corneum Gigeriae Galli 20, Rhizoma Alismatis 20, Fructus Hordei Germinatus 15, Herba Taraxaci 18, Fructus Amomi 10, Pericarpium Citri Reticulatae 15.
Embodiment 6: Flos puerariae lobatae 17, Herba Artemisiae Scopariae 20, Endothelium Corneum Gigeriae Galli 16, Rhizoma Alismatis 24, Fructus Hordei Germinatus 10, Herba Taraxaci 20, Fructus Amomi 7, Pericarpium Citri Reticulatae 10.
Embodiment 7: Flos puerariae lobatae 9, Radix Schisandrae Bicoloris 14, Endothelium Corneum Gigeriae Galli 15, Rhizoma Alismatis 20, Fructus Hordei Germinatus 10, Herba Taraxaci 17, Fructus Amomi 8, Pericarpium Citri Reticulatae 9, Semen Pharbitidis 10, Rhizoma Atractylodis 20.
Claims (3)
1, a kind of Chinese medicine oral liquid for the treatment of alcoholic liver disease, it is characterized in that, wherein medicinal raw material comprises, in parts by weight: Flos puerariae lobatae or Radix Puerariae 0.5～20, Radix Schisandrae Bicoloris or Herba Artemisiae Scopariae 1～20, Endothelium Corneum Gigeriae Galli 1～20, Rhizoma Alismatis 0.5～24, Fructus Hordei Germinatus 1～15, Herba Taraxaci 1～20, Fructus Amomi 0.1～10, Pericarpium Citri Reticulatae 1～15.
2, oral liquid according to claim 1 is characterized in that described Chinese crude drug raw material comprises: Flos puerariae lobatae 0.5～20, Radix Schisandrae Bicoloris 1～20, Endothelium Corneum Gigeriae Galli 1～20, Rhizoma Alismatis 0.5～24, Fructus Hordei Germinatus 1～15, Herba Taraxaci 1～20, Fructus Amomi 0.1～10, Pericarpium Citri Reticulatae 1～15.
3, oral liquid according to claim 1 and 2 is characterized in that adding in the described Chinese crude drug raw material Semen Pharbitidis 0.5～10 and Rhizoma Atractylodis 1～20.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100436717A CN100335114C (en) | 2005-05-26 | 2005-05-26 | Chinese medicinal liquor for treating alcoholic liver disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100436717A CN100335114C (en) | 2005-05-26 | 2005-05-26 | Chinese medicinal liquor for treating alcoholic liver disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1698747A CN1698747A (en) | 2005-11-23 |
| CN100335114C true CN100335114C (en) | 2007-09-05 |
Family
ID=35475100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100436717A Expired - Fee Related CN100335114C (en) | 2005-05-26 | 2005-05-26 | Chinese medicinal liquor for treating alcoholic liver disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100335114C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101264169B (en) * | 2007-03-18 | 2011-08-24 | 徐向田 | Alcohol-clearing liver nourishing capsule and manufacturing technique |
| CN102885989A (en) * | 2012-08-22 | 2013-01-23 | 谢美云 | Medicinal and edible health care product for protecting against chemical liver injury and preparation method for health care product |
| CN109315667A (en) * | 2018-09-29 | 2019-02-12 | 首益特殊医学用途配方食品科技研究（北京）有限公司 | Diet therapy nutritional element solid beverage and preparation method thereof for hepatitis |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1528429A (en) * | 2003-10-20 | 2004-09-15 | 上海澳博海洋生物技术开发有限公司 | Chinese medicine preparation with accessory protection action to alcoholic liver injury and preparing method thereof |
-
2005
- 2005-05-26 CN CNB2005100436717A patent/CN100335114C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1528429A (en) * | 2003-10-20 | 2004-09-15 | 上海澳博海洋生物技术开发有限公司 | Chinese medicine preparation with accessory protection action to alcoholic liver injury and preparing method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 清肝活血方治疗酒精性肝病的临床研究 季光，中西医综合学报，第1卷第2期 2003 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1698747A (en) | 2005-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101342317B (en) | Medicament composition for treating tuberculosis and preparation method thereof | |
| CN1720945A (en) | Medicine for treating calculus in urinary system | |
| CN1742939A (en) | Medicine for treating pulmonary fibrosis and preparing method | |
| CN104623201A (en) | Medicine for protecting liver, removing toxicity, reducing blood lipid and reducing blood sugar and application thereof | |
| CN1403146A (en) | Medicines composition for treating diabetes and its prepn | |
| CN1814215A (en) | Medicine for treating gout and gout arthritis | |
| CN100335114C (en) | Chinese medicinal liquor for treating alcoholic liver disease | |
| CN1130219C (en) | Litholysizing bear gall powder | |
| CN101152354A (en) | Traditional Chinese medicine for treating acute dacryocystitis | |
| CN1137720C (en) | Chinese medicine for treating diabetes and its complication | |
| CN101049438A (en) | Composition of Chinese traditional medicine for treating coronary heart disease | |
| CN101112475A (en) | Chinese traditional medicine composition for treating diabetes and the complication | |
| CN1056755C (en) | Medicine of curing hepatitis | |
| CN102488846A (en) | Medicinal composition for treating diabetes mellitus | |
| CN101584813A (en) | Traditional Chinese medicine for treating facial paralysis | |
| CN101152343A (en) | Traditional Chinese medicine for treating chronic dacryocystitis | |
| CN1907353A (en) | Chinese traditional medicine preparation for treating chronic gastritis | |
| CN1911308A (en) | Medicine for treating infantile anorexia, and its prepn. method | |
| CN1078905A (en) | A kind of medicine for external use for the treatment of hepatopathy | |
| CN1634279A (en) | Chinese traditional medicine for treating diabetes | |
| CN1156292C (en) | Medicine for curing cholecystitis and its preparing method | |
| CN104107352A (en) | Chinese herbal medicine for blood pressure reducing, and administration method thereof | |
| CN1062172C (en) | Medicine for treating cervical spondylopathy | |
| CN102380048B (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN1903301A (en) | Traditional Chinese medicine oral liquor for treating prostate diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070905 Termination date: 20160526 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |